Consumer Staples
Star Combo Pharma Limited (S66)
Star Combo Pharma Limited (ASX: S66) is an ASX-listed manufacturer and distributor of herbal and vitamin supplements, operating primarily in Australia and China. Key products include vitamin D, probiotic, and ginseng-based health supplements. Listed since 16 May 2018.
Market Cap
A$32M
Shares on Issue
N/A
Price Chart
AI Analysis
Star Combo Pharma currently maintains a modest market presence in the competitive Australian and Chinese health supplement markets. Recent performance has been volatile, reflective of its small market cap (A$32M) and sector competition. Key metrics include a growing revenue stream from Chinese exports.
Growth prospects hinge on successful product launches in the Australian market and expansion of its Chinese distribution network. Strategic partnerships or acquisitions could serve as upcoming catalysts, though the company’s direction remains focused on organic growth for now.
Bull Case
- • Successful entry into high-demand Chinese health supplement markets boosts revenue significantly.
- • Australian product line expansion attracts major retail partnerships, increasing visibility.
- • Strategic partnership with a larger player enhances global distribution capabilities.
Bear Case
- • Intensified competition in the Australian market erodes existing market share.
- • Chinese regulatory changes impact supplement approvals and sales.
- • _failure to achieve profitability within the next 2 years leads to investor fatigue.
Recent Announcements
Quarterly Activities Report
Highlights production updates, capital allocation priorities, and FY guidance commentary.
Investor Presentation
Strategic outlook with market positioning and growth pipeline.
FAQs
What does S66 do?
Star Combo Pharma manufactures and distributes herbal and vitamin supplements in Australia and China.
Is S66 a good investment?
S66 offers speculative growth potential, particularly for those bullish on the Asian health supplements market. However, its small cap size and competitive sector pose significant risks.
What drives S66's share price?
Drivers include Chinese export revenue growth, success of new product launches in Australia, and any strategic partnerships or regulatory approvals in target markets.
Key Metrics
Related Stocks
Consumer Staples
A2MThe A2 Milk Company Limited
A$8.53
7.6% 1Y
The A2 Milk Company Limited operates in the consumer staples sector, focusing on milk and related products. It develops, markets, and distributes A2 dairy products, primarily in New Zealand, Australia, China, and the United States. Key products include A2 Ultra millions, A2 Organic milk, and infant formula.
Consumer Staples
AACAustralian Agricultural Company Limited.
A$1.33
-8.3% 1Y
Australian Agricultural Company (AAC) is one of Australia's largest beef producers and landholders, primarily focused on breeding, raising, and marketing Wagyu and other premium beef brands. Operating vast cattle stations across Northern Australia, the company manages the full supply chain from pasture to plate, including properties, cattle, and feedlots. Its key products include high-quality Wagyu beef sold globally under brands like Master Kobe and Wylarah.
Consumer Staples
AAPAustralian Agricultural Projects Limited
A$0.05
6.8% 1Y
Australian Agricultural Projects Ltd is an agribusiness company focused on the management and operation of olive groves in Victoria, Australia. The company's primary activities involve the harvesting and processing of olives to produce premium extra virgin olive oil for both domestic and international markets. Additionally, AAP provides horticultural management and consulting services for its own and third-party agricultural assets.